Lutetium therapy

Arrangements prior to treatment

Once the decision to proceed has been taken the team should:

Eligibility for therapy for all patients will be discussed in a multidisciplinary setting.

* In patients where this may be a concern, particularly those with metastatic carcinoid syndrome, a baseline echocardiogram should be performed pre-treatment prior to discussion about patient eligibility for Lu-177 treatment.

Patients attend M30 clinic 2 weeks before each treatment cycle to ensure that they meet the criteria for subsequent treatment. Treatment cycles are approximately every 12-16 weeks for 3 - 4 cycles.